Thailand FDA periodically releases a list of institutional review boards (IRBs) / ethics committees (ECs) that it recognizes for acceptance of clinical trials. Under Thailand regulatory system, approved ethics committees serve as the main point of approvals for initiating clinical trials in the country. This has been explained in our previous articles (see Part I […]

Read More →

Thailand is the second-largest healthcare market in Southeast Asia after Indonesia making up roughly about 20% of the region’s expenditure. Thailand’s pharmaceutical market is the eighth largest in the Asia Pacific region and is considered one of the largest and most developed in ASEAN. Top 5 reasons to choose Thailand as your generic drug market Thailand’s generic […]

Read More →

Taiwan is emerging as a big player in the Asian clinical trial market. Taiwan has many advantages for conducting clinical trials. Refer to Part 1 of this blog for more details. In this part, let’s talk a bit about the clinical trial regulatory scenario in Taiwan, including the approvals required and how to be prepared for it. Top […]

Read More →

Recently, the Thailand FDA has brought a revised list of Institutional Review Boards (IRBs)/Ethics Committees (ECs) that it recognizes for acceptance of clinical trial applications. In our previous articles (see Part I and Part II), we’ve discussed the regulatory scenario in Thailand, including regulatory approvals for the clinical trial in Thailand, ethics committee approval for the clinical trial […]

Read More →

Taiwan has one of the most progressive healthcare systems in the world and is a major hub for clinical research in the Asia-Pacific region. Currently, it is well-positioned to meet the growing demands of the global clinical trial market. World-class, high-quality infrastructure, low cost, easy patient recruitment process due to dense populations are a few of the […]

Read More →

Among 10 ASEAN countries, Thailand registers the highest number of clinical trials in the region, and the number of BA/BE studies is increasing. An interest in understanding the regulatory and approval process in Thailand is expected for being such a preferred destination to conduct clinical trials. Continuation from Thailand’s Clinical Trial Regulatory Scenario – Simplified (1/2). […]

Read More →

Among 10 ASEAN countries, Thailand registers the highest number of clinical trials in the region, and the number of BA/BE studies is increasing. An interest in understanding the regulatory and approval process in Thailand is expected for being such a preferred destination to conduct clinical trials. There is an increasing interest in the conduct of […]

Read More →